Scailyte Strengthens Its Leadership | Newswire
Scailyte appoints Tim Foley as Chief Business Officer, Jean-Pierre Rosat as Executive Chair, and Darrin Crisitello as member of the BoD Scailyte, a pioneer in...
Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, proudly announces the appointment of Virginia Savova, PhD as a strategic and scientific advisor. Dr....
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
InSyBio, a leading biotechnology company that has developed a suite of advanced AI tools for biomarker discovery in clinical and multi-omics data, has announced a...
New Progerin Biomarker Predicts Survival Benefits of Treatment in Children With Progeria
Biomarker has future applications in new drug candidate identification and could be used in broader cardiovascular and aging-related research. A newly developed progerin biomarker indicates...